FDA – Study of sex differences in the clinical evaluation of medical products
FDA has issued a draft guidance to provide recommendations for increasing enrolment of females in clinical trials, analysing and interpreting sex-specific data, and including sex-specific information in regulatory submissions of medical products. When finalized, this guidance will...





